Researchers at the University of Chicago Medicine Comprehensive Cancer Center aim to explore ways to slow or stop the growth of tumors that don’t respond to medication by utilizing artificial ...
For decades, drug developers have followed a familiar playbook: isolate a disease-causing protein, develop a biochemical assay, find molecules that bind to it, and then hope those compounds work in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback